← Back to Clinical Trials
Recruiting NCT05939453

NCT05939453 Impact of Bright Light Therapy on Prader-Willi Syndrome

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05939453
Status Recruiting
Phase
Sponsor Maimonides Medical Center
Condition Prader-Willi Syndrome
Study Type INTERVENTIONAL
Enrollment 50 participants
Start Date 2023-10-01
Primary Completion 2026-06

Trial Parameters

Condition Prader-Willi Syndrome
Sponsor Maimonides Medical Center
Study Type INTERVENTIONAL
Phase N/A
Enrollment 50
Sex ALL
Min Age 6 Years
Max Age 88 Years
Start Date 2023-10-01
Completion 2026-06
Interventions
Sham LightBright Light Therapy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This is a placebo controlled clinical trial to assess the utility of light therapy as a sufficient treatment for excessive daytime sleepiness in patients with Prader-Willi Syndrome

Eligibility Criteria

Inclusion Criteria: * Diagnosis of PWS confirmed by genetic testing * Score of 12 or above on the Epworth Sleepiness Scale (ESS). Exclusion Criteria: * Subjects with an eye condition that could be negatively affected by bright light such as patients with a history of retinal damage or patients needing photosensitizing medications * A history of previous treatment with LT * Patients presenting with active psychosis or mania

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology